S100A9 and myelodysplastic syndrome: Akin to human MDS, S100A9Tg mice, where S100A9 expression is driven by the H2K (myeloid) promoter, display age-dependent activation of MDSC that results in hematopoietic progenitor cell death and dysplastic, ineffective hematopoiesis [9].